Literature DB >> 8573127

Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures.

P Chiozzi1, M Murgia, S Falzoni, D Ferrari, F Di Virgilio.   

Abstract

J774 mouse macrophages express an ionotropic receptor gated by extracellular ATP. Activation of this receptor, currently named purinergic P2Z, causes transmembrane ion fluxes, plasma membrane depolarization, cell swelling and eventual cell death. The physiological role of this receptor is as yet unknown. In the present report we show that macrophage cell clones that hypo-express the P2Z receptor showed a very low degree of spontaneous cell death in culture, while hyper-expressing clones were exceedingly susceptible to cell death. To further support a role for ATP receptors in spontaneous cell death, addition to the macrophage cell cultures of oxidized ATP, a selective inhibitor of ionotropic purinergic receptors, or the ATP-hydrolysing enzyme apyrase, also reduced spontaneous death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8573127     DOI: 10.1006/bbrc.1996.0031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Oxidized ATP protection against anthrax lethal toxin.

Authors:  Mahtab Moayeri; Katherine E Wickliffe; Jason F Wiggins; Stephen H Leppla
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

Review 3.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

4.  Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes.

Authors:  C B Grahames; A D Michel; I P Chessell; P P Humphrey
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 5.  Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.

Authors:  Tamás Deli; László Csernoch
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

6.  Lysosomal alkalinization, lipid oxidation, and reduced phagosome clearance triggered by activation of the P2X7 receptor.

Authors:  Sonia Guha; Gabriel C Baltazar; Erin E Coffey; Leigh-Anne Tu; Jason C Lim; Jonathan M Beckel; Shaun Patel; Thor Eysteinsson; Wennan Lu; Ann O'Brien-Jenkins; Alan M Laties; Claire H Mitchell
Journal:  FASEB J       Date:  2013-08-20       Impact factor: 5.191

7.  P2X(7): a growth-promoting receptor-implications for cancer.

Authors:  Francesco Di Virgilio; Davide Ferrari; Elena Adinolfi
Journal:  Purinergic Signal       Date:  2009-03-04       Impact factor: 3.765

8.  Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis.

Authors:  Elena Adinolfi; Maria Giulia Callegari; Maria Cirillo; Paolo Pinton; Carlotta Giorgi; Dario Cavagna; Rosario Rizzuto; Francesco Di Virgilio
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

9.  P2X7 receptor as a novel drug delivery system to increase the entrance of hydrophilic drugs into cells during photodynamic therapy.

Authors:  Paulo Anastácio Furtado Pacheco; Leonardo Braga Gomes Ferreira; Leonardo Mendonça; Dinarte Neto M Ferreira; Juliana Pimenta Salles; Robson Xavier Faria; Pedro Celso Nogueira Teixeira; Luiz Anastacio Alves
Journal:  J Bioenerg Biomembr       Date:  2016-07-15       Impact factor: 2.945

10.  Extracellular ATP is cytotoxic to mononuclear phagocytes but does not induce killing of intracellular Mycobacterium avium subsp. paratuberculosis.

Authors:  Seng-Ryong Woo; Raúl G Barletta; Charles J Czuprynski
Journal:  Clin Vaccine Immunol       Date:  2007-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.